Ataluren use in patients with nonsense mutation Duchenne muscular dystrophy: patient demographics and characteristics from the STRIDE Registry
Ataluren (Translarna) drug for Duchenne Muscular Dystrophy | New Drug Approvals
PTC Therapeutics Announces European Medicines Agency Validation of Marketing Authorization Application for Ataluren in Duchenne Muscular Dystrophy
PTC Receives Positive CHMP Opinion For Translarna In DMD
Andy Biotech on Twitter: "EMA CHMP Jan Meeting Highlights http://t.co/0wgIFR8c6r Negative on $PTCT ataluren, $TEVA $ACTI.ST laquinimod, etc http://t.co/QvuSFipItp" / Twitter
NHS England Enables Access to Translarna™ ▽ (ataluren) For Patients with Nonsense Mutation Duchenne Muscular Dystrophy
EMA Validates PTC Therapeutics' Submission for New Nonsense Mutation Cystic Fibrosis Indication for Translarna (Ataluren)
Ataluren | C15H9FN2O3 - PubChem
Clinical trial phase and FDA/ EMA approval status of available gene... | Download Scientific Diagram
Ataluren - an overview | ScienceDirect Topics
EMA reconsiders 'read-through' drug against Duchenne muscular dystrophy following appeal | Nature Biotechnology
Meta-analyses of ataluren randomized controlled trials in nonsense mutation Duchenne muscular dystrophy
Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet
Translarna, INN-ataluren
Ataluren---EMA批准的蛋白表达修复新药
An overview of Translarna - Action Duchenne
Translarna, INN-ataluren
Biomedicines | Free Full-Text | Novel Translational Read-through–Inducing Drugs as a Therapeutic Option for Shwachman-Diamond Syndrome
Ataluren (Translarna) drug for Duchenne Muscular Dystrophy | New Drug Approvals
Ataluren: An Investigational Dystrophin Restoration Drug for Nonsense Mutation Duchenne Muscular Dystrophy
Frontiers | Off-Label Use of Ataluren in Four Non-ambulatory Patients With Duchenne Muscular Dystrophy: Effects on Cardiac and Pulmonary Function and Muscle Strength
Translarna™ (ataluren) - Genpharm
CHMP summary of positive opinion for Translarna
Translarna (ataluren) for the Treatment of Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) - Clinical Trials Arena
